Spire Healthcare Group PLC (SPI) Earns Add Rating from Numis Securities Ltd
Spire Healthcare Group PLC (LON:SPI)‘s stock had its “add” rating reaffirmed by analysts at Numis Securities Ltd in a research report issued on Wednesday. They presently have a GBX 360 ($4.70) price objective on the stock. Numis Securities Ltd’s price objective suggests a potential downside of 8.44% from the stock’s previous close.
Other analysts also recently issued reports about the stock. Berenberg Bank restated a “buy” rating and issued a GBX 395 ($5.16) target price on shares of Spire Healthcare Group PLC in a report on Wednesday, June 8th. Morgan Stanley reiterated an “equal weight” rating and set a GBX 340 ($4.44) price target on shares of Spire Healthcare Group PLC in a report on Thursday, August 25th. Jefferies Group reiterated a “hold” rating and set a GBX 335 ($4.37) price target on shares of Spire Healthcare Group PLC in a report on Thursday, August 25th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a GBX 433 ($5.65) price target on shares of Spire Healthcare Group PLC in a report on Friday, July 15th. Finally, Barclays PLC reiterated an “overweight” rating and set a GBX 382 ($4.99) price target on shares of Spire Healthcare Group PLC in a report on Friday, August 26th. Five research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Spire Healthcare Group PLC presently has a consensus rating of “Hold” and an average price target of GBX 372.50 ($4.86).
Spire Healthcare Group PLC (LON:SPI) opened at 396.10 on Wednesday. The company’s market cap is GBX 1.58 billion. Spire Healthcare Group PLC has a 52 week low of GBX 275.00 and a 52 week high of GBX 411.00. The firm’s 50 day moving average is GBX 360.25 and its 200-day moving average is GBX 344.03.
The business also recently disclosed a dividend, which will be paid on Tuesday, December 13th. Shareholders of record on Thursday, November 17th will be given a GBX 1.30 ($0.02) dividend. The ex-dividend date is Thursday, November 17th. This represents a yield of 0.37%.
In other Spire Healthcare Group PLC news, insider Gordon,Simon sold 92,174 shares of the business’s stock in a transaction dated Tuesday, August 30th. The shares were sold at an average price of GBX 350 ($4.57), for a total value of £322,609 ($421,105.60). Also, insider Gildersleeve,John acquired 57,300 shares of the stock in a transaction on Wednesday, September 21st. The stock was bought at an average cost of GBX 390 ($5.09) per share, with a total value of £223,470 ($291,698.21).
About Spire Healthcare Group PLC
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Stock Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related stocks with our FREE daily email newsletter.